The bioinformatics services market is witnessing significant growth, driven by advancements in genomics, increasing demand for personalized medicine, and the integration of artificial intelligence (AI) in data analysis.

The global bioinformatics services market size was valued at USD 5.34 billion in 2024 and is expected to grow from USD 6.51 billion in 2025 to USD 18.13 billion by 2032, registering a compound annual growth rate (CAGR) of 15.8% during the forecast period.

Top Companies in the Market

• Illumina, Inc. (U.S.)
• QIAGEN (Netherlands)
• CD Genomics (U.S.)
• Excelra (U.S.)
• Creative Proteomics (U.S.)
• Fios Genomics (U.K.)
• Thermo Fisher Scientific Inc. (U.S.)
• Eurofins Scientific (Luxembourg)
• Psomagen (U.S.)

Key Industry Development

In June 2023, Psomagen expanded its service offerings by adding the Pacific Bioscience Revio system to its sequencing platform. This addition enables services such as whole genome sequencing, whole exome sequencing, single-cell and bulk RNA sequencing, microbiome analysis, and Olink proteomics.

Market Drivers & Restraints

Drivers

• Advancements in Genomic Research: The decreasing cost of sequencing technologies has made genomic research more accessible, leading to increased demand for bioinformatics services.
• Personalized Medicine: The shift towards personalized medicine requires comprehensive data analysis, which bioinformatics services provide, facilitating tailored treatment plans.